1. Home
  2. ICON vs BJDX Comparison

ICON vs BJDX Comparison

Compare ICON & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Icon Energy Corp.

ICON

Icon Energy Corp.

HOLD

Current Price

$2.23

Market Cap

1.3M

Sector

N/A

ML Signal

HOLD

Logo Bluejay Diagnostics Inc.

BJDX

Bluejay Diagnostics Inc.

HOLD

Current Price

$0.86

Market Cap

1.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICON
BJDX
Founded
2023
2015
Country
Greece
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3M
1.2M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
ICON
BJDX
Price
$2.23
$0.86
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$22.50
N/A
AVG Volume (30 Days)
2.0M
138.5K
Earning Date
04-02-2026
11-07-2025
Dividend Yield
2070.49%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,449,000.00
N/A
Revenue This Year
$128.63
N/A
Revenue Next Year
$10.92
$55.56
P/E Ratio
N/A
N/A
Revenue Growth
96.44
N/A
52 Week Low
$1.94
$0.63
52 Week High
$440.00
$10.20

Technical Indicators

Market Signals
Indicator
ICON
BJDX
Relative Strength Index (RSI) 59.13 55.19
Support Level $1.94 $0.63
Resistance Level $3.10 $0.80
Average True Range (ATR) 0.43 0.07
MACD 0.05 0.04
Stochastic Oscillator 44.99 90.92

Price Performance

Historical Comparison
ICON
BJDX

About ICON Icon Energy Corp.

Icon Energy Corp is a growth-oriented shipping company providing seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels. The company generates its revenues by chartering its vessels to regional and international dry bulk operators, commodity traders and end users.

About BJDX Bluejay Diagnostics Inc.

Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from 'sample-to-result' to help medical professionals make earlier and better triage/treatment decisions.

Share on Social Networks: